Consolidated Statements of Cash Flows (USD $) | | |
In Millions | 6 Months Ended
Jul. 04, 2009
| 6 Months Ended
Jun. 28, 2008
|
Segment Manufacturing Group Member | | |
Cash flows from operating activities: | | |
Net income (loss) | $146 | $454 |
Income from discontinued operations | 47 | 14 |
Income (loss) from continuing operations | 99 | 440 |
Adjustments to reconcile income (loss) from continuing operations to net cash provided by (used in) operating activities: | | |
Dividends received from the Finance group | 184 | 142 |
Capital contribution paid to Finance group | (88) | 0 |
Non-cash items: | | |
Depreciation and amortization | 178 | 180 |
Asset impairment charges | 52 | 0 |
Share-based compensation | 18 | 27 |
Amortization of interest expense on convertible notes | 5 | 0 |
Deferred income taxes | (3) | 8 |
Changes in assets and liabilities: | | |
Accounts receivable, net | 70 | (90) |
Inventories | 81 | (632) |
Other assets | (44) | 76 |
Accounts payable | (382) | 229 |
Accrued and other liabilities | (256) | 27 |
Other operating activities, net | 34 | 28 |
Net cash provided by (used in) operating activities of continuing operations | (52) | 435 |
Net cash used in operating activities of discontinued operations | (12) | (31) |
Net cash provided by (used in) operating activities | (64) | 404 |
Cash flows from investing activities: | | |
Net cash used in acquisitions | 0 | (100) |
Capital expenditures | (113) | (188) |
Proceeds from sale of property, plant and equipment | 2 | 1 |
Other investing activities, net | (18) | 0 |
Net cash provided by (used in) investing activities of continuing operations | (129) | (287) |
Net cash provided by (used in) investing activities of discontinued operations | 261 | (6) |
Net cash provided by (used in) investing activities | 132 | (293) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (869) | 82 |
Proceeds from long-term lines of credit | 1,230 | 0 |
Payments on long-term lines of credit | (28) | 0 |
Principal payments on long-term debt | (30) | (47) |
Payments on borrowings against officers life insurance policies | (410) | 0 |
Intergroup financing | 133 | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 |
Purchase of convertible note hedge | (140) | 0 |
Proceeds from issuance of common stock and warrants | 333 | 0 |
Proceeds from option exercises | 0 | 38 |
Purchases of Textron common stock | 0 | (134) |
Dividends paid | (10) | (106) |
Net cash provided by (used in) financing activities of continuing operations | 791 | (167) |
Net cash used in financing activities of discontinued operations | 0 | (2) |
Net cash provided by (used in) financing activities | 791 | (169) |
Effect of exchange rate changes on cash and cash equivalents | 6 | 11 |
Net increase (decrease) in cash and cash equivalents | 865 | (47) |
Cash and cash equivalents at beginning of period | 531 | 471 |
Cash and cash equivalents at end of period | 1,396 | 424 |
Segment Finance Group Member | | |
Cash flows from operating activities: | | |
Net income (loss) | (118) | 35 |
Income (loss) from continuing operations | (118) | 35 |
Non-cash items: | | |
Depreciation and amortization | 19 | 19 |
Provision for losses on finance receivables held for investment | 163 | 67 |
Portfolio losses on finance receivables | 60 | 0 |
Gains on extinguishment of debt | (39) | 0 |
Deferred income taxes | (123) | (41) |
Changes in assets and liabilities: | | |
Other assets | 26 | 20 |
Accrued and other liabilities | 63 | (8) |
Other operating activities, net | 21 | (9) |
Net cash provided by (used in) operating activities of continuing operations | 72 | 83 |
Net cash provided by (used in) operating activities | 72 | 83 |
Cash flows from investing activities: | | |
Finance receivables originated or purchased | (2,234) | (6,338) |
Finance receivables repaid | 2,873 | 5,690 |
Proceeds on receivables sales, including securitizations | 184 | 617 |
Capital expenditures | 0 | (6) |
Proceeds from sale of repossessed assets and properties | 127 | 9 |
Purchase of marketable securities | 0 | (100) |
Other investing activities, net | 61 | (6) |
Net cash provided by (used in) investing activities of continuing operations | 1,011 | (134) |
Net cash provided by (used in) investing activities | 1,011 | (134) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (759) | (48) |
Proceeds from long-term lines of credit | 1,740 | 0 |
Proceeds from issuance of long-term debt | 16 | 1,122 |
Principal payments on long-term debt | (1,405) | (886) |
Intergroup financing | (112) | 0 |
Capital contributions paid to Finance group | 88 | 0 |
Dividends paid | (184) | (142) |
Net cash provided by (used in) financing activities of continuing operations | (616) | 46 |
Net cash provided by (used in) financing activities | (616) | 46 |
Effect of exchange rate changes on cash and cash equivalents | 6 | 1 |
Net increase (decrease) in cash and cash equivalents | 473 | (4) |
Cash and cash equivalents at beginning of period | 16 | 60 |
Cash and cash equivalents at end of period | 489 | 56 |
Consolidated | | |
Cash flows from operating activities: | | |
Net income (loss) | 28 | 489 |
Income from discontinued operations | 47 | 14 |
Income (loss) from continuing operations | (19) | 475 |
Non-cash items: | | |
Depreciation and amortization | 197 | 199 |
Provision for losses on finance receivables held for investment | 163 | 67 |
Portfolio losses on finance receivables | 60 | 0 |
Asset impairment charges | 52 | 0 |
Gains on extinguishment of debt | (39) | 0 |
Share-based compensation | 18 | 27 |
Amortization of interest expense on convertible notes | 5 | 0 |
Deferred income taxes | (126) | (33) |
Changes in assets and liabilities: | | |
Accounts receivable, net | 70 | (90) |
Inventories | 75 | (644) |
Other assets | (12) | 103 |
Accounts payable | (382) | 229 |
Accrued and other liabilities | (193) | 19 |
Captive finance receivables, net | 84 | 23 |
Other operating activities, net | 55 | 19 |
Net cash provided by (used in) operating activities of continuing operations | 8 | 394 |
Net cash used in operating activities of discontinued operations | (12) | (31) |
Net cash provided by (used in) operating activities | (4) | 363 |
Cash flows from investing activities: | | |
Finance receivables originated or purchased | (1,950) | (5,818) |
Finance receivables repaid | 2,505 | 5,257 |
Proceeds on receivables sales, including securitizations | 184 | 507 |
Net cash used in acquisitions | 0 | (100) |
Capital expenditures | (113) | (194) |
Proceeds from sale of property, plant and equipment | 2 | 1 |
Proceeds from sale of repossessed assets and properties | 127 | 9 |
Purchase of marketable securities | 0 | (100) |
Other investing activities, net | 64 | (1) |
Net cash provided by (used in) investing activities of continuing operations | 819 | (439) |
Net cash provided by (used in) investing activities of discontinued operations | 261 | (6) |
Net cash provided by (used in) investing activities | 1,080 | (445) |
Cash flows from financing activities: | | |
Increase (decrease) in short-term debt | (1,628) | 34 |
Proceeds from long-term lines of credit | 2,970 | 0 |
Payments on long-term lines of credit | (28) | 0 |
Proceeds from issuance of long-term debt | 16 | 1,122 |
Principal payments on long-term debt | (1,435) | (933) |
Payments on borrowings against officers life insurance policies | (410) | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 |
Purchase of convertible note hedge | (140) | 0 |
Proceeds from issuance of common stock and warrants | 333 | 0 |
Proceeds from option exercises | 0 | 38 |
Purchases of Textron common stock | 0 | (134) |
Dividends paid | (10) | (106) |
Net cash provided by (used in) financing activities of continuing operations | 250 | 21 |
Net cash used in financing activities of discontinued operations | 0 | (2) |
Net cash provided by (used in) financing activities | 250 | 19 |
Effect of exchange rate changes on cash and cash equivalents | 12 | 12 |
Net increase (decrease) in cash and cash equivalents | 1,338 | (51) |
Cash and cash equivalents at beginning of period | 547 | 531 |
Cash and cash equivalents at end of period | $1,885 | $480 |